Allscripts Healthcare Stock
Your prediction
Allscripts Healthcare Stock
Allscripts Healthcare took a tumble today and lost -€0.200 (-5.560%).
Pros and Cons of Allscripts Healthcare in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allscripts Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allscripts Healthcare | -5.560% | 0.000% | -5.556% | -63.043% | -60.000% | -80.117% | -70.435% |
| MicroVision Inc | -1.310% | 2.121% | -0.777% | 0.941% | -47.643% | -70.634% | -65.396% |
| Fonar Corp. New | 2.480% | 0.000% | -2.362% | -15.068% | -12.676% | -25.301% | -21.519% |
| Fluidigm Corp. | 0.000% | 3.333% | 25.253% | -30.726% | -27.485% | 0.040% | -75.715% |
Comments
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at TD Cowen from $26.00 to $15.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat